ACC/AHA Dyslipidemia Guidelines 2026: Top 10 Updates Clinicians Must Know
Cardiovascular disease remains the leading cause of death worldwide, and aggressive lipid management remains one of the most effective ways to reduce risk. The latest ACC/AHA dyslipidemia guideline updates (released March 2026) reinforce aggressive LDL-C reduction, emphasize earlier risk assessment, and expand the role of non-statin therapies. For busy clinicians in primary care, cardiology, and […]
ACC/AHA Dyslipidemia Guidelines 2026: Top 10 Updates Clinicians Must Know Read More »










